Morgan Stanley: China’s pharmaceutical exports grow, but pressure on API prices persists
Pharmaceutical exports rose 10.5% year on year in the first three quarters of 2026, but the trade deficit still widened to 21 billion US dollars. Morgan Stanley says excess capacity and low utilization continue to suppress active pharmaceutical ingredient (API) prices, prompting some manufacturers to move into finished formulations or CDMO services.